BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12383891)

  • 1. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer.
    Julian TB; Dusi D; Wolmark N
    Am J Surg; 2002 Oct; 184(4):315-7. PubMed ID: 12383891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer.
    Brady EW
    Breast J; 2002; 8(2):97-100. PubMed ID: 11896755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
    Enokido K; Watanabe C; Nakamura S; Ogiya A; Osako T; Akiyama F; Yoshimura A; Iwata H; Ohno S; Kojima Y; Tsugawa K; Motomura K; Hayashi N; Yamauchi H; Sato N
    Clin Breast Cancer; 2016 Aug; 16(4):299-304. PubMed ID: 26993216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node biopsy is a reliable method for lymph node evaluation in neoadjuvant chemotherapy-treated patients with breast cancer.
    Koslow SB; Eisenberg RE; Qiu Q; Chen Z; Swistel A; Shin SJ
    Am Surg; 2014 Feb; 80(2):171-7. PubMed ID: 24480218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
    Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
    Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The feasibility and the role of sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer].
    Péley G; Török K; Farkas E; Mátrai Z; Horváth Z; Sinkovics I; Hitre E; Rényi-Vámos F; Orosz Z; Köves I
    Magy Onkol; 2006; 50(1):19-23. PubMed ID: 16617379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node biopsy performed before preoperative chemotherapy for axillary lymph node staging in breast cancer.
    Schrenk P; Hochreiner G; Fridrik M; Wayand W
    Breast J; 2003; 9(4):282-7. PubMed ID: 12846861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
    Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
    Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.
    Nason KS; Anderson BO; Byrd DR; Dunnwald LK; Eary JF; Mankoff DA; Livingston R; Schmidt RA; Jewell KD; Yeung RS; Moe RE
    Cancer; 2000 Dec; 89(11):2187-94. PubMed ID: 11147588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
    Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF
    Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of sentinel node biopsy before and after neoadjuvant chemotherapy: timing is important.
    Jones JL; Zabicki K; Christian RL; Gadd MA; Hughes KS; Lesnikoski BA; Rhei E; Specht MC; Dominguez FJ; Smith BL
    Am J Surg; 2005 Oct; 190(4):517-20. PubMed ID: 16164912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.
    Breslin TM; Cohen L; Sahin A; Fleming JB; Kuerer HM; Newman LA; Delpassand ES; House R; Ames FC; Feig BW; Ross MI; Singletary SE; Buzdar AU; Hortobagyi GN; Hunt KK
    J Clin Oncol; 2000 Oct; 18(20):3480-6. PubMed ID: 11032588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in breast cancer patients treated with neoadjuvant chemotherapy.
    Pecha V; Kolarik D; Kozevnikova R; Hovorkova K; Hrabetova P; Halaska M; Sottner O; Trnkova M; Petruzelka L; Kolarova H
    Cancer; 2011 Oct; 117(20):4606-16. PubMed ID: 21437896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sentinel lymphadenectomy combined with intraoperative ultrasound in the assessment of locally advanced breast cancer after neoadjuvant chemotherapy.
    Yu JC; Hsu GC; Hsieh CB; Yu CP; Chao TY
    Ann Surg Oncol; 2007 Jan; 14(1):174-80. PubMed ID: 17066228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.
    Mamounas EP; Brown A; Anderson S; Smith R; Julian T; Miller B; Bear HD; Caldwell CB; Walker AP; Mikkelson WM; Stauffer JS; Robidoux A; Theoret H; Soran A; Fisher B; Wickerham DL; Wolmark N
    J Clin Oncol; 2005 Apr; 23(12):2694-702. PubMed ID: 15837984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer. Its relation with molecular subtypes].
    Ruano R; Ramos M; García-Talavera JR; Ramos T; Rosero AS; González-Orus JM; Sancho M
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):340-5. PubMed ID: 24856234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel node mapping performed before preoperative chemotherapy may avoid axillary dissection in breast cancer patients with negative or micrometastatic sentinel nodes.
    Schrenk P; Tausch C; Wölfl S; Bogner S; Fridrik M; Wayand W
    Am J Surg; 2008 Aug; 196(2):176-83. PubMed ID: 18513692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate axillary nodal staging can be achieved after neoadjuvant therapy for locally advanced breast cancer.
    Patel NA; Piper G; Patel JA; Malay MB; Julian TB
    Am Surg; 2004 Aug; 70(8):696-9; discussion 699-700. PubMed ID: 15328803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.